Cargando…
Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019
The causative agent for coronavirus disease 2019, severe acute respiratory syndrome coronavirus 2, appears exceptional in its virulence and immunopathology. In some patients, the resulting hyperinflammation resembles a cytokine release syndrome. Our knowledge of the immunopathogenesis of coronavirus...
Autores principales: | Buckley, Leo F., Wohlford, George F., Ting, Clara, Alahmed, Abdullah, Van Tassell, Benjamin W., Abbate, Antonio, Devlin, John W., Libby, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419062/ https://www.ncbi.nlm.nih.gov/pubmed/32832913 http://dx.doi.org/10.1097/CCE.0000000000000178 |
Ejemplares similares
-
Erratum. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP. Diabetes Care 2017;40:1733–1738
por: Buckley, Leo F., et al.
Publicado: (2018) -
A phase 1 clinical trial of SP16, a first-in-class anti-inflammatory LRP1 agonist, in healthy volunteers
por: Wohlford, George F., et al.
Publicado: (2021) -
Metabolic modulation predicts heart failure tests performance
por: Contaifer, Daniel, et al.
Publicado: (2019) -
Acute Effects of Liothyronine Administration on Cardiovascular System and Energy Metabolism in Healthy Volunteers
por: Chen, Shanshan, et al.
Publicado: (2022) -
C-Reactive Protein and N-Terminal Pro-brain Natriuretic Peptide Levels Correlate With Impaired Cardiorespiratory Fitness in Patients With Heart Failure Across a Wide Range of Ejection Fraction
por: van Wezenbeek, Jessie, et al.
Publicado: (2018)